VivaDiag SARS-CoV-2 Ag Fast Check relies on immunoassay know-how for the speedy, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human oropharyngeal or nasopharyngeal swab specimens. The check generates a end result inside 15 minutes figuring out individuals contaminated with COVID-19 rapidly serving to to comprise the unfold of the virus.
The package comprises all gadgets required together with swab, extraction tube, extraction resolution and lateral circulation check system. No specialised gear or personnel is required to make use of this check. The assessments may be carried out in any setting at any time by educated personnel, i.e for skilled use solely
This lateral circulation Covid-19 Fast Antigen Check Equipment is for easy for educated personnel to manage delivering correct outcomes quickly utilizing the oropharyngeal or nasopharyngeal swab specimen.
With the specimen collected insert the swab into the extraction tube stuffed with extraction resolution. Having eliminated a testing system from the sealed pouch apply three drops of the answer and wait 15 minutes earlier than studying the check, a optimistic or detrimental result’s clearly indicated.
This Covid-19 Fast Antigen Check Equipment has an general accuracy of 98.79%, a specificity of 99.12% and a sensitivity of 90.90% offering full assurance of quick, correct, dependable outcomes.
These assessments must be used as a part of a totally built-in COVID-19 technique, serving to determine these contaminated to cut back the unfold of the virus. VivaDiag™ SARS-CoV-2 Ag Fast Check has ONLY been designed to behave as a supplementary check for suspected instances of detrimental coronavirus nucleic acid detection or along with nucleic acid detection within the analysis of suspected instances. Outcomes from nucleocapsid protein antigen testing shouldn’t be used as the only real foundation to diagnose or exclude SARS-CoV-2 (COVID-19) an infection or to tell an infection standing.

Precept and meant use
Immupass VivaDiag SARS-CoV-2 Ag Fast Check is meant for medical laboratories and healthcare skilled use just for point-of-care testing. Not for at-home testing.
Immupass VivaDiag™ SARS-CoV-2 Ag Fast Check relies on immunoassay know-how. Every check system has one line of anti-SARS coronavirus monoclonal antibody on the detection line (T line) and one line of anti-mouse IgG polyclonal antibody on the standard management line (C line).
When extracted specimen is added to the specimen properly, it should react with the labeled antibody to type a posh, the combination then migrates by way of the membrane by capillary motion and interacts with the coated anti-SARS coronavirus monoclonal antibody on the detection line. If the specimen comprises SARS-CoV-2 antigen, the detection line will seem purplish-red indicating the SARS-CoV-2 antigen is optimistic. In any other case, the check end result shall be detrimental. The check system additionally comprises a top quality management line C which ought to seem purplish-red for all legitimate assessments. If the standard management line C doesn’t seem, the check end result shall be invalid even when the detection line seems.
Composition
Every check package comprises: 25 check gadgets, 25 extraction tubes (prefilled with extraction resolution 300 μL / tube), filtered nozzles, 1 tube stand, 25 sterile swabs and 1 bundle insert.
Supplies required however could not supplied: timer.
Specification
Check Precept | Colloidal gold |
Pattern Kind | Nasal swab, oropharyngeal swab or nasopharyngeal swab |
Pattern Quantity | 60 μL |
Check Time | 15 min |
Operation Temperature | 15-30℃ |
Storage Temperature | 2-30℃ |
Shelf Life (Unopened) | 24 months |
SARS-CoV-2 Rapid Antigen Test Nasal |
|||
9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 112.8 |
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
IOV87952 | INVBIO | 20T/kit | EUR 46.8 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-20tests | Accu test | 20 tests | EUR 283.2 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-40tests | Accu test | 40 tests | EUR 385.2 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Panbio™ COVID-19 Ag Rapid Test Device |
|||
41FK10 | Abbott | 25 Tests/Kit | EUR 115.2 |
Dynamiker Monkeypox Virus Ag Rapid Test |
|||
DNK-2114-1 | Dynamiker Biotechnology | 20 tests | EUR 702 |
Description: The product is a lateral flow chromatographic immunoassay for the qualitative detection of monkeypox virus antigen in human whole blood, serum, plasma or rash exuudate. The kit is intended for professional use only. |
Panbio™ COVID-19 Ag Rapid Test Device (Nasal) |
|||
41FK11 | Abbott | 25 Tests/Kit | EUR 128 |
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19 |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|||
GEN-402-25tests | All test | 25 tests | EUR 292.8 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
Rapid Response COVID-19 Saliva Rapid Antigen Test |
|||
BSV-COV-2C25B | BioServUK | 25 tests | Ask for price |
Description: Rapid Response COVID-19 Saliva Rapid Antigen Test |
COVID-19 IgG/IgM Rapid Test Kit |
|||
UNCOV-20 | UnScience | 20T/kit | EUR 186 |
Description: COVID-19 IgG/IgM Rapid Test (Serum/Plasma/Whole Blood) is a qualitative membrane-based immunoassay for the detection of COVID-19 antibodies in serum, plasma, or whole blood. This test consists of two test lines, an IgG line and an IgM line, which is pre-coated with two mouse anti-human monoclonal antibodies separately. During testing, the sample reacts with COVID-19 antigen-coated on conjugated pad. As the complex continues to travel up the strip, the anti-COVID-19 IgM antibodies are bound on the IgM line, and the anti-COVID-19 IgG antibodies are bound on the IgG line. The control(C)line appears when sample has flowed through the strip. The presence of anti-COVID-19 IgM and/or IgG will be indicated by a visible test line in the IgM and IgG region. To serve as a procedural control, the control line should always appear if the test procedure is performed properly and the reagents are working as intended. |
Melamine Rapid Test Kit |
|||
abx092011-50tests | Abbexa | 50 tests | EUR 444 |
Innovita COVID-19 IgG/IgM Rapid Test |
|||
BSV-RAPID-02 | BioServUK | 40 tests | Ask for price |
Description: Innovita COVID-19 IgG/IgM Rapid Test |
GA COVID-19 Rapid Antigen Test |
|||
BSV-3980 | BioServUK | 20 tests | Ask for price |
Description: GA COVID-19 Rapid Antigen Test |
COVID-19 Antigen Rapid Test Pen (Saliva) |
|||
BSV-COV-2PEN20 | BioServUK | 20 pc | Ask for price |
Description: COVID-19 Antigen Rapid Test Pen (Saliva) |
Panbio™ COVID-19 IgG/IgM Rapid Test |
|||
ICO-T402 | Abbott | 25 Tests/Kit | EUR 264 |
Melamine (MEL) Rapid Test Kit |
|||
abx092057-50tests | Abbexa | 50 tests | EUR 444 |
Quinolones (QNs) Rapid Test Kit |
|||
abx092065-40tests | Abbexa | 40 tests | EUR 477.6 |
Salbutamol (SAL) Rapid Test Kit |
|||
abx092060-50tests | Abbexa | 50 tests | EUR 292.8 |
Quinolones (QNs) Rapid Test Kit |
|||
abx092067-40tests | Abbexa | 40 tests | EUR 477.6 |
Clenbuterol (CLE) Rapid Test Kit |
|||
abx092058-50tests | Abbexa | 50 tests | EUR 292.8 |
Ractopamine (RAC) Rapid Test Kit |
|||
abx092059-50tests | Abbexa | 50 tests | EUR 292.8 |
Tetracycline (TCs) Rapid Test Kit |
|||
abx092063-50tests | Abbexa | 50 tests | EUR 477.6 |
Sulfonamides (Sas) Rapid Test Kit |
|||
abx092064-40tests | Abbexa | 40 tests | EUR 477.6 |
Brucella Antibody Rapid Test Kit |
|||
abx092069-40tests | Abbexa | 40 tests | EUR 427.2 |
Ciprofloxacin (CPFX) Rapid Test Kit |
|||
abx092066-50tests | Abbexa | 50 tests | EUR 477.6 |